课题基金 / 基金详情

Novel transgenesis and expression technology for nematodes

Novel transgenesis and expression technology for nematodes
线虫新型转基因和表达技术
批准号:
10186102
负责人:
MICHAEL L NONET
金额:
$26.99万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-30 至 2024-05-31

项目摘要

项目成果

MICHAEL L NONET的其他基金

相似基金

相关文献

中文摘要
翻译
重组DNA技术在几乎每一个使用该技术的研究项目中都发挥着不可或缺的作用。 C. elegans模型来剖析介导人类许多方面的保守生物学机制, 健康与疾病的生物学虽然CRISPR技术的发展彻底改变了 科学家有能力对基因组进行微小的修改,创造出含有 大的多酶插入物仍然是费力的。这些类型的转基因动物需要 解剖细胞机制的许多关键方面,包括在特定细胞中表达基因 类型,标记和可视化亚细胞成分,监测信号分子的浓度 使用基因编码的传感器,并使用RNA干扰干扰细胞功能, 选择性蛋白质降解技术。我最近开发了一种新的重组酶介导的 C.将转基因频率提高了五倍 超过目前的技术。此外,我使用这种新颖的技术开发了四个双向报告器, 用于线虫以促进转基因工具的稳健表达的系统。虽然小说 方法是对当前方法的重大改进,它仍然大于 比CRISPR技术效率更低。在开发过程中获得的见解 技术指出了关键的限制,这一赠款旨在克服,以进一步提高效率, 方法。此外,由于使用Flp,新方法具有显著的局限性 和Cre重组酶。这项赠款还建议进一步技术发展的方法, 克服这些限制。成功实施拟议的工作将具有极大的 对C.通过极大地促进转基因开发, 这是许多研究项目的共同瓶颈。
英文摘要
Recombinant DNA technology plays an integral role in virtually every research program using the C. elegans model to dissect conserved biological mechanisms that mediate many aspects of human biology in health and disease. While the development of CRISPR technology has revolutionized the ability of scientists to make small modification of the genome, creating transgenic animals that contain large multi-kilobase inserts remains laborious. These types of transgenic animals are required for many critical aspects of dissecting cellular mechanisms including to express genes in specific cell types, to tag and visualize sub-cellular components, to monitor concentrations of signaling molecules using genetically encoded sensors, and to perturb cellular functions using RNA interference and selective protein degradation technologies. I have recently developed a novel recombinase-mediated cassette exchange approach for C. elegans that increases the frequency of transgenesis about five-fold over current techniques. Furthermore, I used this novel technology to develop four bipartite reporter systems for use in nematodes to facilitate robust expression of transgenic tools. While the novel approach is a significant improvement over current approaches, it remains greater than an order of magnitude less efficient than CRISPR technology. Insights made during the development of the technique point to critical limitations that this grant aims to overcome to further increase the efficiency of the approach. Furthermore, the new approach comes with significant limitations due to the use of Flp and Cre recombinases. This grant also proposes further technological development of the approach to overcome these limitations. Successful implementation of the proposed work would have extreme impact on the C. elegans research community by greatly facilitating transgene development removing this common bottleneck for many research programs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel transgenesis and expression technology for nematodes
  • 批准号:
    10620801
  • 项目类别:
  • 资助金额:
    $27.56万
  • 财政年份:
    2021
  • 负责人:
    MICHAEL L NONET
  • 依托单位:
GENETICALLY ENCODED SPARSE LABELING AND EXPRESSION FOR IN VIVO STUDIES
  • 批准号:
    8823435
  • 项目类别:
  • 资助金额:
    $7.63万
  • 财政年份:
    2014
  • 负责人:
    MICHAEL L NONET
  • 依托单位:
GENETICALLY ENCODED SPARSE LABELING AND EXPRESSION FOR IN VIVO STUDIES
  • 批准号:
    8904738
  • 项目类别:
  • 资助金额:
    $7.63万
  • 财政年份:
    2014
  • 负责人:
    MICHAEL L NONET
  • 依托单位:
QUANTIFYING CELLULAR COMPLEX COMPOSITION IN VIVO
  • 批准号:
    8397006
  • 项目类别:
  • 资助金额:
    $22.8万
  • 财政年份:
    2012
  • 负责人:
    MICHAEL L NONET
  • 依托单位:
海外基金